Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3004 Target Snapshot

Multidrug resistance-associated protein 1 · SINGLE PROTEIN · Homo sapiens

1,730Compounds
445Assays
18Approved Drugs
1,081.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P33527. Use UniProt P33527 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P33527 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Multidrug resistance-associated protein 1 as ChEMBL target CHEMBL3004, mapped to UniProt P33527. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Multidrug resistance-associated protein 1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL3004
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P33527
Multidrug resistance-associated protein 1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Multidrug resistance-associated protein 1 is the right protein anchor across sources, using UniProt P33527 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMultidrug resistance-associated protein 1
UniProt AccessionP33527
Component TypeProtein
Sequence Length1531 aa

Multidrug resistance-associated protein 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Multidrug resistance-associated protein 1, mapped to UniProt P33527. Sequence length is 1531 aa.

Mapped IDP33527
Review nameMultidrug resistance-associated protein 1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

18
Approved
3
Phase III
6
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC50716.0
KI40.0
EC50323.0
KD2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL58 8.82 IC50 1.5 Approved
CHEMBL28629 8.0 IC50 10.0 Preclinical
CHEMBL281496 8.0 IC50 10.0 Preclinical
CHEMBL26779 7.96 IC50 11.0 Preclinical
CHEMBL25903 7.92 IC50 12.0 Preclinical
CHEMBL26150 7.92 IC50 12.0 Preclinical
CHEMBL25905 7.89 IC50 13.0 Preclinical
CHEMBL29743 7.86 IC50 13.7 Preclinical
CHEMBL281326 7.82 IC50 15.0 Preclinical
CHEMBL418382 7.77 IC50 17.0 Preclinical
Distribution

pChEMBL Value Distribution

129
5.0
96
5.5
126
6.0
110
6.5
40
7.0
17
7.5
2
8.0
3
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

MITOXANTRONE
CHEMBL58
Approved 1987
VERAPAMIL
CHEMBL6966
Approved 1981
DAUNORUBICIN
CHEMBL178
Approved 1979
ESTRONE SULFURIC ACID
CHEMBL494753
Approved 1977
Assay Landscape

Assay Landscape

451
Total Assays
494
Tested Compounds
3
Assay Types
Binding — 262 assays, 494 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 238 346 5.4
single protein format 15 14 5.6
assay format 9 134 6.7
Functional — 166 assays, 58 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 94 32 5.9
cell membrane format 65 26 5.8
subcellular format 4 0
assay format 2 0
organism-based format 1 0
ADME — 23 assays, 2 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 14 1 5.8
mitochondrion format 4 0
assay format 2 0
cell membrane format 2 0
single protein format 1 1 4.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine